ENGLEWOOD, CO / ACCESSWIRE / February 11, 2021 / Aytu BioScience, Inc. (NASDAQ: AYTU), reported financial results for its fiscal second quarter ending December 31, 2020, last week, and disclosed completion of the first clinical study evaluating the company’s Healight™ ultraviolet A light catheter technology. “This is an important milestone, and we look forward to continuing discussions with the FDA…
Aytu BioScience Completes Clinical Trial of Healight™ UV-A Light Catheter Technology
More from ProductMore posts in Product »
- US Patent Issued 2025 – US 12329865 B2 “Self-sanitizing system for vehicle cabins”
- US Patent Issued 2025 – US 12329867 B2 “Methods and systems for treatment of vehicle surfaces and air”
- US Patent Application – US 20250197926 A1 “SYSTEM FOR DISINFECTING TEXTILES IN A HOUSEHOLD APPLIANCE
- Self-Contained Dianostic Tool “H3 Health Cube”Now Active In Market
- US Patent Application – US 20250186638 A1 “Method and Technique for the Focusing of UVC Light Energy to a Focused Energy Beam”